KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Cash (2016 - 2026)

Medtronic (MDT) has disclosed Change in Cash for 13 consecutive years, with -$136.0 million as the latest value for Q1 2026.

  • Quarterly Change in Cash rose 11.69% to -$136.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$94.0 million through Jan 2026, up 75.46% year-over-year, with the annual reading at $934.0 million for FY2025, 460.62% up from the prior year.
  • Change in Cash hit -$136.0 million in Q1 2026 for Medtronic, down from $9.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $2.7 billion in Q4 2022 to a low of -$3.0 billion in Q2 2023.
  • Historically, Change in Cash has averaged -$103.2 million across 5 years, with a median of -$28.0 million in 2023.
  • Biggest five-year swings in Change in Cash: soared 2684.62% in 2022 and later crashed 3600.0% in 2025.
  • Year by year, Change in Cash stood at $2.7 billion in 2022, then plummeted by 101.04% to -$28.0 million in 2023, then surged by 396.43% to $83.0 million in 2024, then crashed by 89.16% to $9.0 million in 2025, then plummeted by 1611.11% to -$136.0 million in 2026.
  • Business Quant data shows Change in Cash for MDT at -$136.0 million in Q1 2026, $9.0 million in Q4 2025, and -$945.0 million in Q3 2025.